Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Itching can be an early sign of hyperthyroidism.

People with alopecia areata have higher levels of a heart disease marker in their blood.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.

TNF-inhibitor induced alopecia can be treated effectively with different therapies.

SH-SY5Y cell lysate is effective for diagnosing Satoyoshi syndrome.

Cells from a skin condition can create new hair follicles and similar growths in mice, and a specific treatment can reduce these effects.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Overt hyperthyroidism is the most common thyroid disorder, especially in women.

Two specific SNPs in the TRPS1 gene cause excessive hair growth by altering the protein's structure.

JAK inhibitors like baricitinib are a new FDA-approved treatment for alopecia areata, but safety data is incomplete.

Good medication adherence improves quality of life in subclinical thyroid disorder patients.

PTHRP agonists can stimulate hair growth, especially in damaged follicles, while antagonists may initially increase growth but ultimately inhibit it.

Topical immunotherapy for alopecia areata may work by creating immune cell clusters in the skin.

Toluene diisocyanate exposure can cause immune sensitization by interacting with proteins in hair follicles and sebaceous glands.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Allergies, especially dust mite allergy, may worsen alopecia areata, and desensitization could help reduce its severity.

JAK inhibitors can help regrow hair in alopecia areata but have potential long-term risks and require careful monitoring.

JAK inhibitors are effective treatments for alopecia areata.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Total testosterone levels can help diagnose androgen-producing tumors and hyperandrogenism in women.

Tamoxifen can cause total hair loss but its benefits outweigh this side effect.

Too much parathyroid hormone-related protein in skin disrupts hair growth in mice.

A patient's grey hair regained color during treatment with adalimumab.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.